Log In
BCIQ
Print this Print this
 

Advate, octocog alfa

Also known as: Recombinant Factor VIII (Factor VIII - protein-free method (rAHF-PFM)) (rAHF-PFM)

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionRecombinant Factor VIII (rFVIII)
Molecular Target Factor VIII
Mechanism of ActionProcoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat bleeding in patients with hemophilia A
Regulatory Designation
PartnerBaxalta Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$32,000.0M

$12,639.9M

0


 Deals Details
Get a free BioCentury trial today